Quantas Bioscience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Quantas Bioscience
Quantas Bioscience Private Limited (QBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2022 (Two years and ten months 26 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gayathiri Ponnusamy and Subburaj Mamitha serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290TZ2022PTC038403
-
Company No.
038403
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Quantas Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gayathiri Ponnusamy
|
Director | 09-Mar-2022 | Current |
|
Subburaj Mamitha
|
Director | 05-Dec-2023 | Current |
Financial Performance of Quantas Bioscience.
Enhance accessibility to Quantas Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantas Bioscience?
Unlock access to Quantas Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Empera Biopharma Private LimitedGayathiri Ponnusamy is a mutual person
-
Empera Health Service Private Limited
Gayathiri Ponnusamy is a mutual person
-
Empera Holdings Private Limited
Gayathiri Ponnusamy is a mutual person
-
Empera Meditech Private Limited
Gayathiri Ponnusamy and Subburaj Mamitha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quantas Bioscience?
Unlock and access historical data on people associated with Quantas Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantas Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantas Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
